{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0007413455",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Alzinova AB (First North Sweden: SE0007413455) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Alzinova AB, listed on First North Sweden under ticker SE0007413455, with ISIN SE0007413455 and LEI 549300K3IMVT20EK2S13. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 47 filings on 43 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6.0 days. The latest filing is dated 2026-11-03, 3 days before the record date of 2026-11-06, and is of type Investor News. The exchange median for First North Sweden is 11.0 days of cadence, 21 filings and 7 days of latency across 325 issuers. The sector median is not on the record.\n\n## Auditor\n\nThe auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule version acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page.\n\n## Open research\n\nThe record holds 4 openly published research notes: BioStock Analytics on 2026-07-07, Carnegie Securities Research on 2025-01-27, Redeye on 2023-02-23, and Redeye on 2021-11-01.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0007413455 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.alzinova.com/wp-content/uploads/2026/07/alzinova-ab-commissioned-valuation-analysis-biostock-analytics-july2026.pdf (open research)\n- https://www.alzinova.com/wp-content/uploads/2025/02/alzi_250127.pdf (open research)\n- https://www.alzinova.com/wp-content/uploads/2023/02/redeye-updated-report-2023-02-23.pdf (open research)\n- https://www.alzinova.com/wp-content/uploads/2021/11/redeye_report_2021-11-01.pdf (open research)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0007413455 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0007413455",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://www.alzinova.com/investors/the-share/analyst-coverage/",
     "result": "not readable by this rail (404)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Company Announcement": 24,
    "Company description / prospectus": 1,
    "Corporate Action": 1,
    "Decisions of general meeting": 1,
    "Financial calendar": 1,
    "Financial statement release": 1,
    "Half year financial report": 2,
    "Interim report (Q1 and Q3)": 3,
    "Investor News": 8,
    "Notice to general meeting": 1,
    "Other information disclosed according to the rules of the Exchange": 3
   },
   "cadence_median_gap_days": 6,
   "filing_days": 43,
   "filings": 47,
   "latency_days": 3,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-11-03",
     "source": "https://view.news.eu.nasdaq.com/view?id=b54a526d37a30529430358c83bc18f585&lang=en&src=listed",
     "title": "Alzinova moves closer to Phase 2a initiation with US ethics submission",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-11-02",
     "source": "https://view.news.eu.nasdaq.com/view?id=bd797b2a40d2b462e8b217d4b22c73c76&lang=en&src=listed",
     "title": "Alzinova takes further step toward Phase 2a ADVANCE study with submitted FDA amendment for ALZ-101",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-21",
     "source": "https://view.news.eu.nasdaq.com/view?id=b424bea12d77abc22378ccd53e63c0df0&lang=en&src=listed",
     "title": "Alzinova finalises selection of seven US clinical sites as ADVANCE Phase 2a study moves toward first participant enrolment",
     "type": "Investor News"
    },
    {
     "category": "Company Announcement",
     "date": "2026-10-20",
     "source": "https://view.news.eu.nasdaq.com/view?id=bd0669db2699229a7b6f56e57a49ed062&lang=en&src=listed",
     "title": "Alzinova's Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue",
     "type": "Company Announcement"
    },
    {
     "category": "Investor News",
     "date": "2026-10-08",
     "source": "https://view.news.eu.nasdaq.com/view?id=bcd870de1ed62ee6fd79a381d95b43d5b&lang=en&src=listed",
     "title": "Alzinova to present latest developments in ALZ-101 and blood-based diagnostics at Redeye Neurology Day",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-11-03",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0007413455",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0007413455"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0007413455)",
    "state": "sourced",
    "value": "549300K3IMVT20EK2S13"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Alzinova AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0007413455"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:a1b73dd42f8c8b9ff00d7eb735eace5bce96e7672defb8ce42dbe0bf3bedcb63",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2026-07-07",
     "kind": "issuer-sponsored",
     "publisher": "BioStock Analytics",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.alzinova.com/wp-content/uploads/2026/07/alzinova-ab-commissioned-valuation-analysis-biostock-analytics-july2026.pdf",
     "state": "sourced",
     "title": "Alzinova AB · Commissioned Valuation Analysis"
    },
    {
     "date": "2025-01-27",
     "kind": "issuer-sponsored",
     "publisher": "Carnegie Securities Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.alzinova.com/wp-content/uploads/2025/02/alzi_250127.pdf",
     "state": "sourced",
     "title": "Alzinova"
    },
    {
     "date": "2023-02-23",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.alzinova.com/wp-content/uploads/2023/02/redeye-updated-report-2023-02-23.pdf",
     "state": "sourced",
     "title": "Update"
    },
    {
     "date": "2021-11-01",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://www.alzinova.com/wp-content/uploads/2021/11/redeye_report_2021-11-01.pdf",
     "state": "sourced",
     "title": "Ready to ignite – Initiating clinical development"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0007413455",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a1b73dd42f8c8b9ff00d7eb735eace5bce96e7672defb8ce42dbe0bf3bedcb63",
 "path": "/se/SSME/SE0007413455",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Alzinova AB, listed on First North Sweden under ticker SE0007413455, with ISIN SE0007413455 and LEI 549300K3IMVT20EK2S13. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 47 filings on 43 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6.0 days. The latest filing is dated 2026-11-03, 3 days before the record date of 2026-11-06, and is of type Investor News. The exchange median for First North Sweden is 11.0 days of cadence, 21 filings and 7 days of latency across 325 issuers. The sector median is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule version acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 4 openly published research notes: BioStock Analytics on 2026-07-07, Carnegie Securities Research on 2025-01-27, Redeye on 2023-02-23, and Redeye on 2021-11-01.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0007413455"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://www.alzinova.com/wp-content/uploads/2026/07/alzinova-ab-commissioned-valuation-analysis-biostock-analytics-july2026.pdf"
  },
  {
   "for": "open research",
   "source": "https://www.alzinova.com/wp-content/uploads/2025/02/alzi_250127.pdf"
  },
  {
   "for": "open research",
   "source": "https://www.alzinova.com/wp-content/uploads/2023/02/redeye-updated-report-2023-02-23.pdf"
  },
  {
   "for": "open research",
   "source": "https://www.alzinova.com/wp-content/uploads/2021/11/redeye_report_2021-11-01.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0007413455"
  }
 ],
 "title": "Alzinova AB (SE0007413455) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}